Direct Flow Medical

Direct Flow Medical

Transcatheter heart valve technologies that improve patient outcomes while reducing patient complications.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
N/A

€0.0

round
investor investor investor investor investor investor

€0.0

round
investor investor investor investor investor investor investor investor

€0.0

round
investor investor investor investor investor investor investor

€0.0

round
investor investor

€0.0

round
investor investor

€0.0

round
investor investor investor investor investor investor investor investor

€0.0

round
N/A

$27.1m

Series A
Total Funding000k
More about Direct Flow Medical
Made with AI
Edit

Direct Flow Medical specializes in providing effective solutions for erectile dysfunction and benign prostatic hyperplasia through its flagship product, Tadalafil, sold under the brand name Cialis. The company operates in the pharmaceutical market, targeting adult men who experience these medical conditions. Direct Flow Medical's business model revolves around the sale of both branded and generic versions of Cialis, offering various dosages to meet different patient needs. Revenue is generated through direct sales to consumers via their online platform, as well as through partnerships with healthcare providers and pharmacies. The company emphasizes the long-lasting effects of its product, which can last up to 36 hours, and its ability to work independently of food intake, setting it apart from many other erectile dysfunction drugs.

Keywords: erectile dysfunction, benign prostatic hyperplasia, Tadalafil, Cialis, pharmaceutical, long-lasting, online sales, healthcare partnerships, adult men, smooth muscle relaxation.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo